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Better value primary care is needed now more than
ever
Effective primary care is essential to deliver high value care, but change needs to be driven by
evidence based policy and investment, argue Jessica Watson and colleagues
Jessica Watson NIHR doctoral research fellow 1, Chris Salisbury professor of primary healthcare 1,
Anant Jani honorary research fellow 2, Muir Gray honorary professor 2, Brian McKinstry professor
of primary care e-health 3, Rebecca Rosen senior fellow 4
1Centre for Academic Primary Care, University of Bristol, Bristol BS8 2PS, UK; 2Value Based Healthcare Programme, Nuffield Department of Primary
Care Health Sciences, University of Oxford, Oxford, UK; 3Usher Institute of Population Health Sciences and Informatics, University of Edinburgh,
Edinburgh, UK; 4Nuffield Trust, London, UK
Healthcare systems globally are facing multiple challenges, with
ageing populations, increasing chronic disease, rising
multimorbidity, and innovative treatments and technologies all
leading to rising costs. With finite resources, and an increasing
recognition of the potential harms to patients of overdiagnosis
and overtreatment,1 it is essential that resources are used
optimally. We explore how the value based healthcare
framework2 can help decisions about how to allocate resources,
and the importance of good evidence not only for patient
treatment but for the organisation of health services.2 3
What do we mean by value in healthcare?
For the past 20 years most of the focus in healthcare has been
on quality, safety, efficiency, and cost effectiveness. However,
it is increasingly clear that these four factors alone are not
sufficient for the 21st century. Care that is apparently high
quality, safe, efficient, and cost effective in other circumstances,
will decrease value when delivered to the wrong patient at the
wrong time. Optimality—defined by Donabedian as “balancing
of improvements in health against the cost of such
improvement”—is important.4
As healthcare resources are increased the benefits initially
increase but then flatten off (fig 1⇓). By contrast, the amount
of harm done increases in direct proportion to the investment
of resources. Consequently, the net benefit rises with increasing
investment until a point of optimality, after which it falls off.
It is at this point that high value care is achieved. For example,
population level reductions in risk factors for cardiovascular
disease have led to large improvements in cardiovascular
mortality.5 However expanding indications for treatment to
include low risk people with mild hypertension takes us beyond
the point of optimality; here evidence of benefit is limited and
side effects can cause harms.6
To achieve value in healthcare optimality must be considered
at the level of the individual (personal value), organisation
(technical value), and population (allocative value). Balancing
allocation to ensure individual and population needs are met
within finite resources is often challenging. For example, drug
treatments for hypertension may deliver a large benefit (eg,
avoiding stroke) for a small number of people, but the harms
(eg, side effects), though relatively small, will affect a very large
number of people. Optimality therefore requires evidence and
shared decision making with individual patients.
Why is value in healthcare important?
Atlases of variation in health and healthcare show substantial
differences in costs, outcome, and quality. For example, in 2013
there was a 57-fold variation between English primary care
trusts in general practitioners’ use of thyroid function tests and
106-fold variation in the use of serum creatinine tests.7 This
unwarranted variation is likely to reflect both overuse and
underuse of healthcare.
Too much medicine, even when the quality is high, can harm
patients.1 Examples include aggressive treatment to reduce
glycated haemoglobin concentrations increasing morbidity and
mortality in elderly people with diabetes,8 and routine screening
for dementia, which risks false positive diagnoses and has no
proved benefit.9 Underuse or lack of access to high value
healthcare services can harm both individuals and populations
by increasing socioeconomic inequalities in health. For example,
pulmonary rehabilitation has been shown to improve the health
of people with chronic obstructive pulmonary disease (COPD)
but people living in more deprived areas who enrol in pulmonary
rehabilitation are less likely to complete it than those living in
less deprived areas.10
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Tackling wasteful spending in healthcare has emerged as a
priority for governments worldwide.11 Around one fifth of health
expenditure has been estimated to make no or minimal
contribution to health outcomes, and health systems will be
unable to cope with the rises in rates of long term conditions
and multimorbidity12 if value is not optimised. Various initiatives
have been developed in response to this challenge such as
RightCare,13 Getting it Right First Time,14 Choosing Wisely15
and minimally disruptive medicine.16 Value based medicine
brings together these concepts within an overarching framework.
Primary care is essential for delivering
value
Optimising primary care is vital to achieve value in healthcare.
In the UK 90% of NHS patient contacts occur in primary care,
which acts as a filter to specialist services. Only 5% of general
practice attendances result in referral to another service.17
Starfield and colleagues studied the association between the
provision of high quality primary care and a country’s health
outcomes and found strong primary care is associated with
improved patient outcomes, reduced health inequalities, and
improved cost effectiveness.18 More recent analysis concluded
that although countries with comprehensive primary care
systems tend to have better outcomes at higher cost, when
primary care doctors act as gate keepers to specialists and
patients are registered with a primary care doctor (as in the
NHS) health spending is lower.19
Primary care excels at high value preventive care, can lead to
decreased disease burden and downstream treatment costs, and
may modify demand in the long term. However, primary care
in England is buckling under increasing demands, with clinical
workload for general practice rising by 16% in seven years.20
Little progress has been made to meet the promise of 5000 extra
GPs by 2020, and the number of full time GPs in England
actually fell in 2016.21 Pressure on GPs may be partly mitigated
by the increasing numbers of allied health professionals, but if
primary care is not strengthened, secondary care could face even
greater burdens. As Roland and Everington stated: “If general
practice fails, the whole NHS fails.”22
Maximising value in primary care
The government response to rising healthcare demands always
seems to be to ask primary care to do more. GPs have been
asked to do more seven day working, more to take pressure off
emergency departments, more to tackle obesity, and more
screening for dementia, to name just a few recent examples. But
if we are to achieve high value primary care, each additional
demand must be weighed up against the opportunity cost. We
need to focus on what low value activities primary care should
be doing less of.
Table 1⇓ gives some opportunities to increase value in primary
care at the individual, organisational, and population level. Many
of these examples, such as reducing unnecessary blood tests,
are important not just in primary care but across all health
services.
How could current changes in primary
care increase (or decrease) value
Primary care in the UK is changing rapidly in response to the
pressures described. Many struggling practices are closing or
merging with other practices, larger practice networks are
growing, and integrated models of care linking community and
hospital services are developing. By sharing ideas and good
practice—for example, through the Royal College of General
Practitioners’ Bright Ideas forum43—we have an opportunity to
rethink or redesign primary care to provide optimal value
healthcare for individuals, organisations, and society.
New models of care such as accountable care systems and
sustainability and transformation partnerships mean that primary
care can influence value throughout the entire health and care
system. Evaluation of the National Association for Primary
Care’s primary care homes, which integrate primary, secondary,
and social care, shows that they have stimulated new ways of
working in areas such as care of elderly people, although data
on patient outcomes are still limited.36
The challenge is to design new organisational forms and care
processes that decrease waste and demedicalise care whenever
possible. These new models of care must be evidence based and
balance benefits against opportunity costs. Some of the recent
demands on primary care have not done this. For example,
moving towards improving access through seven day working
and larger group practices seems laudable, but evidence that
better access leads to improved health outcomes is lacking.44
Furthermore, this could have knock-on effects on continuity of
care, which is not only highly valued by patients and general
practitioners but is also associated with improved patient
outcomes.45 Elderly people who see the same general practitioner
have fewer hospital admissions,23 41 and the rise in hospital
admissions in recent years is due almost entirely to patients who
had accessed emergency departments directly, without going
through their general practitioner.46 We therefore need a public
debate about the relative importance of convenient timely access
versus continuity of care. Making a change that is not
underpinned by a clear rationale and evidence is wasteful.
Effective change
Fundamental questions about how to organise and deliver
primary healthcare require better evidence to guide decisions.
Primary care measurement systems need to be developed to
generate data that can assist with the identification of optimality.
Innovative examples include OpenPrescribing.net, which allows
GP prescribing rates to be compared at a regional and practice
level. Data on rates of consultation, diagnostic testing, referral,
and patient outcomes could help identify outliers, explore trends,
and measure the impact of policy interventions.
The era of evidence based medicine has changed the way
medicine is practised; now it is time for politicians to follow
suit with an era of evidence based policy. This means policy
interventions should be trialled or piloted before implementation
and evidence of benefits must be weighed against the
opportunity costs and potential harms.
We must also remember that change itself requires adequate
investment of time and money. Many primary care organisations
are introducing new multiprofessional roles or bringing in
physician assistants, extended scope specialists (eg,
physiotherapists and pharmacists), and mental health workers.
These new roles and relationships may take years to reach full
potential and require substantial input from senior practice
staff.47 Extra resources will therefore be needed initially and
staff retention is crucial to allow the benefits of these new roles
to be realised.
Finally, although it is important to maximise value through
decisions about how resources are used, this is inextricably
linked to the total resources made available, which is ultimately
a political choice. The proportion of gross domestic product
spent on healthcare is reducing in the UK compared with other
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developed countries, and increasing value can only partially
mitigate the effects. Given limited resource and unending
demand we also need a wider dialogue and debate with citizens
(box 1) and professionals about what we want from the NHS
and what we choose to afford.
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Box 1: A citizen’s perspectives
Yes, better value for money must always be worthwhile. But isn’t the NHS more efficient than most of the competition and aren’t we spending
less on health as a percentage of GDP than most other countries in Europe?
As a (hopefully) healthy retiree, I celebrate, not bewail, the fact that people live longer lives; solutions to problems generally create new
problems. Richer countries always spend more on health services and other services. It’s a sign of wealth.
If the wealthy paid tax as reliably as they used to, and at rates in effect during the post-war economic boom, then we would more easily
afford the NHS now, just as we afforded it then. Healthcare was seen as a marvellous new universal benefit, not a burden.
Vast inequality makes us all ill, insecure, and miserable (in different ways), and it undermines the NHS because the super-rich opt out of
socialised healthcare, spending more on health than may be optimal for them or affordable for society as a whole
Yes, look at value for money in treatment options, private finance initiatives, public-private partnerships, and whatever comes next. Look at
charges in pharmaceuticals and equipment. Look at, and renegotiate, legacy costs. Have the endless reorganisations of healthcare
administration provided value for money? If each was so successful, why was each so soon replaced by the next?
Incentives matter, and they differ. The private sector investor’s incentive is to maximise financial returns. That’s why their dealings need to
be seen and supervised by others and subject to public gaze and assessment. What about patient incentives? A sick person may be relieved
that more can be spent on their health than they could personally afford to insure against. Can patients be expected to look at their own
trauma from a wider perspective? Can specialists be expected to see the costs and benefits of their specialism from a wider perspective?
GPs and public healthcare managers, perhaps uniquely, have a broader brief, charged with the need to optimise quality and cost of healthcare.
They may also prefer a quiet life in the face of local pressures or vested interests. Conversely, senior managers may reorganise the boat
too much, just to prove they made a mark.
Alex Howard is a retired tutor, manager, and writer. He is a lay member of a medical research ethics committee and
chaired a local community health council in the 1980s.
Key messages
Value based healthcare involves balancing improvements in health against the cost of such improvement
Current changes in UK primary care offer opportunities to increase value at the individual, organisational, and population level
Change requires adequate investment and better evidence to guide decisions
Primary care should consider what low value activities to do less of as well as what to do more of
Table
Table 1| Examples of opportunities to improve value in primary care based on personal, technical, and allocative value
Things to do less ofThings to do more of
Personal value (individual)
Tests not influencing management—Tests are often performed for “reassurance,”
yet systematic reviews have shown normal results do not reassure patients25
Continuity of care—Associated with improved patient outcomes and lower
rates of hospital admission.23 24 May require pairing of GPs and shared patients
given an increasingly part-time workforce Polypharmacy—By reducing opioid use, for example. Long acting opioids are
associated with a significantly higher risk of all cause mortality and are often
addictive and ineffective for chronic pain26 27
Social prescribing (community referral)—Means of enabling primary care
professionals to refer people to local, non-clinical services. It may improve
anxiety and could reduce the use of NHS services, although evidence is
limited28 Low value risk modification, particularly for patients with multimorbidity—Guidelineson single health conditions may not be applicable and aggressive management
of risk factors may be an inappropriate treatment burden29Patient self care—Self monitoring and management of long term conditions
may improve health outcomes, improve experience, and reduce costs30 Health checks—Benefits of health checks have not been demonstrated31 and there
is concern that they may overmedicalise the “worried well” and increase health
inequalities32
Shared decision making and “what matters to you” medicine—Sharing the
benefits and harms of preventive treatment may reduce prescribing; less than
a third of patients would take a drug if they thought they had a 5% chance or
less of benefiting33
Technical value (organisational)
Unnecessary appointments—For example, checking blood pressure. Home readings
and phone consultations may be appropriate instead
Information enabled peer review to curb variability within larger primary care
organisations—Examples include Clinical Guardian, an electronic platform for
routine clinical audit of GP out-of-hours clinicians34 Administrative workload for clinicians—Appropriate delegation of tasks to
administrative staff can reduce GP time spent on correspondence35Integration between primary, secondary care, and social care—Examples
include primary care homes, which provide population based care using an
integrated workforce on a larger scale than the traditional practice size. Early
evidence shows these improve interprofessional working, though data to track
progress against defined metrics are needed to measure outcomes36
Non-evidence based technology “solutions”—Although technology may improve
patient care and reduce pressure on health services, particularly for long term
conditions, many apps and devices have not been evaluated and may have harms
or could increase demand.37 For example, increased investment of resources into
telehealth for COPD has been shown to increase primary care workload with no
demonstrable benefit38
Allocative value (population)
Supplier induced demand resulting from broadening routes of access—Additional
NHS services, such as walk in centres, minor injury units, and 111 services, are
often not substitutive and tend to increase overall service use 42
Increased allocation of NHS funding into general practice—The cost of a
hospital stay is estimated at £400/day39 whereas an average general practice
receives £142 per patient a year.40 Increasing general practice funding to
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Table 1 (continued)
Things to do less ofThings to do more of
increase capacity to keep patients out of hospital could increase value—for
example, improving continuity of care has been shown to reduce hospital
admissions41
Reorganisations of healthcare—These incur costs, both financial and in terms of
patient confusion and staff morale
Allocating more pharmacists and extended scope physiotherapists to primary
care to create additional capacity and multiprofessional skill mix
For personal use only: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2017;359:j4944 doi: 10.1136/bmj.j4944 (Published 2017 November 10) Page 5 of 6
ANALYSIS
Figure
Fig 1 Relation between increasing resources and increasing benefits and harms, showing Donabedian’s point of Optimality4
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